Expression of soluble interleukin-6 receptor in malignant ovarian tissue

American Journal of Obstetrics and Gynecology

Volumn 203, Issue 3, 2010, Pages 230.e1-230.e8

  Rath, Kellie S ^a   Funk, Holly M ^a   Bowling, Marcia C ^b   Richards, William E ^a   Drew, Angela F ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CHRIST HOSPITAL   (United States)

Author keywords

a disintegrin and metalloprotease domain 10; a disintegrin and metalloprotease domain 17; cytokine receptor; inflammation; interleukin 6; ovarian tumor

Indexed keywords

INTERLEUKIN 6 RECEPTOR;

ADULT; AGED; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER TISSUE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITHELIUM CELL; FEMALE; HISTOPATHOLOGY; HOST; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; INFLAMMATION; MOUSE; NONHUMAN; OVARY; OVARY CARCINOMA; OVARY TUMOR; PAPILLARY SEROUS OVARIAN CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TUMOR LOCALIZATION; XENOGRAFT;

EID: 77956342801     PISSN: 00029378     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajog.2010.03.034     Document Type: Article

References (36)

1. American Cancer Society Cancer facts and figures www.cancer.org/ downloads/STT/2008CAFFfinalsecured.pdf 2008 Accessed May 5, 2010
2. D.S. Hong, L.S. Angelo, and R. Kurzrock Interleukin-6 and its receptor in cancer: implications for translational therapeutics Cancer 110 2007 1911 1928
3. T. Taga, M. Hibi, and Y. Hirata Interleukin-6 triggers the association of its receptor with a possible signal transducer, gp130 Cell 58 1989 573 581
4. N. Stahl, T.J. Farruggella, T.G. Boulton, Z. Zhong, J.E. Darnell Jr, and G.D. Yancopoulos Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors Science 267 1995 1349 1353
5. Y. Yamanaka, K. Nakajima, T. Fukada, M. Hibi, and T. Hirano Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation EMBO J 15 1996 1557 1565
6. U.M. Wegenka, J. Buschmann, C. Lutticken, P.C. Heinrich, and F. Horn Acute-phase response factor, a nuclear factor binding to acute-phase response elements, is rapidly activated by interleukin-6 at the posttranslational level Mol Cell Biol 13 1993 276 288
7. S.A. Jones, and S. Rose-John The role of soluble receptors in cytokine biology: the agonistic properties of the sIL-6R/IL-6 complex Biochim Biophys Acta 1592 2002 251 263
8. A. Mackiewicz, H. Schooltink, P.C. Heinrich, and S. Rose-John Complex of soluble human IL-6-receptor/IL-6 up-regulates expression of acute-phase proteins J Immunol 149 1992 2021 2027
9. S.A. Jones, P.J. Richards, J. Scheller, and S. Rose-John Review: IL-6 transsignaling: the in vivo consequences J Interferon Cytokine Res 25 2005 241 253
10. C. Becker, M.C. Fantini, and C. Schramm TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling Immunity 21 2004 491 501
11. M.A. Nowell, P.J. Richards, and S. Horiuchi Soluble IL-6 receptor governs IL-6 activity in experimental arthritis: blockade of arthritis severity by soluble glycoprotein 130 J Immunol 171 2003 3202 3209
12. B. Rabe, A. Chalaris, and U. May Transgenic blockade of Interleukin-6-trans-signaling abrogates inflammation Blood 111 2008 1021 1028
13. S. Horiuchi, Y. Koyanagi, and Y. Zhou Soluble interleukin-6 receptors released from T cell or granulocyte/macrophage cell lines and human peripheral blood mononuclear cells are generated through an alternative splicing mechanism Eur J Immunol 24 1994 1945 1948
14. J. Mullberg, H. Schooltink, T. Stoyan, P.C. Heinrich, and S. Rose-John Protein kinase C activity is rate limiting for shedding of the interleukin-6 receptor Biochem Biophys Res Commun 189 1992 794 800
15. W. Thabard, S. Barille, and M. Collette Myeloma cells release soluble interleukin-6R-alpha in relation to disease progression by two distinct mechanisms: alternative splicing and proteolytic cleavage Clin Cancer Res 5 1999 2693 2697
16. J.A. Lust, D.F. Jelinek, and K.A. Donovan Sequence, expression and function of an mRNA encoding a soluble form of the human interleukin-6 receptor (sIL-6R) Curr Top Microbiol Immunol 194 1995 199 206
17. S.A. Jones, D. Novick, S. Horiuchi, N. Yamamoto, A.J. Szalai, and G.M. Fuller C-reactive protein: a physiological activator of interleukin 6 receptor shedding J Exp Med 189 1999 599 604
18. V. Marin, F. Montero-Julian, S. Gres, P. Bongrand, C. Farnarier, and G. Kaplanski Chemotactic agents induce IL-6R-alpha shedding from polymorphonuclear cells: involvement of a metalloproteinase of the TNF-alpha-converting enzyme (TACE) type Eur J Immunol 32 2002 2965 2970
19. V. Matthews, B. Schuster, and S. Schutze Cellular cholesterol depletion triggers shedding of the human interleukin-6 receptor by ADAM10 and ADAM17 (TACE) J Biol Chem 278 2003 38829 38839
20. B. Coles, C.A. Fielding, S. Rose-John, J. Scheller, S.A. Jones, and V.B. O'Donnell Classic interleukin-6 receptor signaling and interleukin-6 trans-signaling differentially control angiotensin II-dependent hypertension, cardiac signal transducer and activator of transcription-3 activation, and vascular hypertrophy in vivo Am J Pathol 171 2007 315 325
21. M.M. Moradi, L.F. Carson, B. Weinberg, A.F. Haney, L.B. Twiggs, and S. Ramakrishnan Serum and ascitic fluid levels of interleukin-1, interleukin-6, and tumor necrosis factor-alpha in patients with ovarian epithelial cancer Cancer 72 1993 2433 2440
22. M. Plante, S.C. Rubin, G.Y. Wong, M.G. Federici, C.L. Finstad, and G.A. Gastl Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer Cancer 73 1994 1882 1888
23. G. Scambia, U. Testa, and P. Benedetti Panici Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer Br J Cancer 71 1995 354 356
24. Z. Duan, R. Foster, and D.A. Bell Signal transducers and activators of transcription 3 pathway activation in drug-resistant ovarian cancer Clin Cancer Res 12 2006 5055 5063
25. R.T. Penson, K. Kronish, and Z. Duan Cytokines IL-1beta, IL-2, IL-6, IL-8, MCP-1, GM-CSF and TNF-alpha in patients with epithelial ovarian cancer and their relationship to treatment with paclitaxel Int J Gynecol Cancer 10 2000 33 41
26. E. Kovacs Investigation of interleukin-6 (IL-6), soluble IL-6 receptor (sIL-6R) and soluble gp130 (sgp130) in sera of cancer patients Biomed Pharmacother 55 2001 391 396
27. T.M. Robinson-Smith, I. Isaacsohn, and C.A. Mercer Macrophages mediate inflammation-enhanced metastasis of ovarian tumors in mice Cancer Res 67 2007 5708 5716
28. A.F. Drew, T.J. Blick, and M.A. Lafleur Correlation of tumor- and stromal-derived MT1-MMP expression with progression of human ovarian tumors in SCID mice Gynecol Oncol 95 2004 437 448
29. M.B. Nilsson, R.R. Langley, and I.J. Fidler Interleukin-6, secreted by human ovarian carcinoma cells, is a potent proangiogenic cytokine Cancer Res 65 2005 10794 10800
30. D.L. Silver, H. Naora, J. Liu, W. Cheng, and D.J. Montell Activated signal transducer and activator of transcription (STAT) 3: localization in focal adhesions and function in ovarian cancer cell motility Cancer Res 64 2004 3550 3558
31. V. Syed, G. Ulinski, S.C. Mok, and S.M. Ho Reproductive hormone-induced, STAT3-mediated interleukin 6 action in normal and malignant human ovarian surface epithelial cells J Natl Cancer Inst 94 2002 617 629
32. S.A. Jones, S. Horiuchi, D. Novick, N. Yamamoto, and G.M. Fuller Shedding of the soluble IL-6 receptor is triggered by Ca2+ mobilization, while basal release is predominantly the product of differential mRNA splicing in THP-1 cells Eur J Immunol 28 1998 3514 3522
33. A. Mantovani, N. Polentarutti, and G. Peri Cytotoxicity on tumor cells of peripheral blood monocytes and tumor-associated macrophages in patients with ascites ovarian tumors J Natl Cancer Inst 64 1980 1307 1315
34. S. Haskill, S. Becker, W. Fowler, and L. Walton Mononuclear-cell infiltration in ovarian cancer I. Inflammatory-cell infiltrates from tumour and ascites material Br J Cancer 45 1982 728 736 (Pubitemid 12122863)
35. B. Melichar, C.A. Savary, R. Patenia, S. Templin, K. Melicharova, and R.S. Freedman Phenotype and antitumor activity of ascitic fluid monocytes in patients with ovarian carcinoma Int J Gynecol Cancer 13 2003 435 443
36. A. Chalaris, B. Rabe, and K. Paliga Apoptosis is a natural stimulus of IL6R shedding and contributes to the proinflammatory trans-signaling function of neutrophils Blood 110 2007 1748 1755